Home / Market News / $OCS

$OCS news and market catalysts

The 4 most recent market catalysts affecting $OCS, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

4 catalysts 1 high impact 2 bullish 1 bearish Biotechnology
Sep 18, 2026 Corporate Catalyst Bullish Impact 65
HC Wainwright & Co. Maintains Buy on Oculis Holding, Raises Price Target to $39
HC Wainwright & Co. analyst Yi Chen has maintained a 'Buy' rating on Oculis Holding (OCS) and raised the price target from $26 to $39. This is a significant upgrade, indicating inc…
Aug 14, 2026 Corporate Catalyst Bearish Impact 55
JP Morgan Maintains Overweight on Oculis Holding, Lowers Price Target to $20
JP Morgan's analyst Tessa Romero has adjusted Oculis Holding's price target downwards from $23 to $20. While the 'Overweight' rating suggests continued confidence in the company's …
Aug 7, 2026 Corporate Catalyst Bullish Impact 92
Oculis Holding Q2 EPS $(0.20) Beats $(0.48) Estimate, Sales $392.150K Beat $260.000K Estimate
Oculis Holding (OCS) announced Q2 earnings that significantly beat analyst expectations, with a loss per share of $(0.20) against an estimate of $(0.48), and sales of $392.150K, su…
Aug 5, 2026 Corporate Catalyst Neutral Impact 55
HC Wainwright & Co. Maintains Buy on Oculis Holding, Maintains $26 Price Target
HC Wainwright & Co. analyst Yi Chen has maintained a 'Buy' rating and a $26 price target on Oculis Holding (OCS). This action signals continued confidence from a research firm in t…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.